San Mateo, CA, United States of America

Sivan Cohen

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Sivan Cohen

Introduction: Sivan Cohen, an innovative inventor based in San Mateo, California, has made significant contributions to the field of biotechnology. With his groundbreaking work at Genentech, Inc., he specializes in developing novel therapeutic solutions, showcasing the power of innovation in improving healthcare.

Latest Patents: Sivan Cohen holds a patent for "FLT3 ligand fusion proteins and methods of use." This invention encompasses an effectorless immunoglobulin Fc protein and the fusions of this protein to a FLT3 ligand. The methods outlined utilize these proteins for various applications, representing a meaningful advancement in the treatment landscape.

Career Highlights: Throughout his career, Sivan has carved a niche in the biotechnology sector, particularly while working at Genentech, Inc. His expertise in immunology and protein engineering has positioned him as a key player in the development of cutting-edge therapeutic strategies.

Collaborations: Sivan Cohen collaborates with notable professionals in his field, including Yichin Liu and Christine Carine Moussion. These collaborations foster an environment of creativity and shared knowledge, driving forward the development of new and effective biotechnological innovations.

Conclusion: Sivan Cohen exemplifies the essence of modern inventorship in biotechnology. With his patent on FLT3 ligand fusion proteins, he continues to pave the way for future discoveries that hold the potential to transform patient care. The collaborative efforts with his colleagues further enhance the impact of his work, making him a noteworthy figure in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…